In Kaplan–Meier survival assay, elevated OGT (P = 2.7 × 10−2 and P = 1.0 × 10−3), FOXC1 (P = 2.2 × 10−14 and P = 4.0 × 10−2), ASNS (P = 2.7 × 10−7 and P = 8.3 × 10−3), GPT2 (P = 1.4 × 10−15 and P = 1.6 × 10−9), CBS (P = 1.5 × 10−16 and P = 1.1 × 10−5), and FTH1 (P = 2.7 × 10−4 and P = 1.5 × 10−2) were associated with poorer prognosis in 498 (GSE62564) and 283 (GSE85047) NB cases (Fig. S11C). This evidence concerns the gene CBS and neuroblastoma.